{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T13:57:37Z","timestamp":1718546257357},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1007\/s002040050197","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:30:30Z","timestamp":1030246230000},"page":"444-449","source":"Crossref","is-referenced-by-count":18,"title":["Subchronic toxicity of 3-phenylamino alanine, an impurity in l-tryptophan reported to be associated with eosinophilia-myalgia syndrome"],"prefix":"10.1007","volume":"69","author":[{"given":"Fumiaki","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"50690444204_CR1","unstructured":"Anonymous (1989) Analysis of l-tryptophan for the etiology of eosinophilia-myalgia syndrome. MMWR 39: 789\u2013790"},{"key":"50690444204_CR2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199008093230601","volume":"323","author":"EA Belongia","year":"1990","unstructured":"Belongia EA, Hedberg CW, Gleich GJ, White KE, Mayeno AN, Loegering DA, Dunnette SL, Pirie PL, McDonald KL, Osterholm MT (1990) An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 323: 357\u2013365","journal-title":"N Engl J Med"},{"key":"50690444204_CR3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0091-6749(91)90157-J","volume":"88","author":"BS Bochner","year":"1991","unstructured":"Bochner BS, Friedman B, Krishnaswami G, Schleimer RP, Lichtenstein LM, Kroegel C (1991) Episodic eosinophilia-myalgia-like syndrome in a patient without l-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor. J Allergy Clin Immunol 88: 629","journal-title":"J Allergy Clin Immunol"},{"issue":"55","key":"50690444204_CR4","first-page":"25","volume":"35","author":"DJ Clauw","year":"1993","unstructured":"Clauw DJ, Scott L, Manz HJ, Kagan E, Katz P (1993a) A rat feeding study using tryptophan implicated as causal in the eosinophilia myalgia syndrome (EMS). Arth Rheum 35:[55]: S25 (abstract)","journal-title":"Arth Rheum"},{"issue":"95","key":"50690444204_CR5","first-page":"114","volume":"36","author":"DJ Clauw","year":"1993","unstructured":"Clauw DJ, Blank C, Tefft M, Sears R, Moscowitz L, Marenco J, Katz P, Manz H (1993b) Features of the eosinophilia myalgia syndrome (EMS) in a mouse model. Arth Rheum 36: [95] S 114 (abstract)","journal-title":"Arth Rheum"},{"key":"50690444204_CR6","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/art.1780370910","volume":"37","author":"DJ Clauw","year":"1994","unstructured":"Clauw DJ, Ward K, Wilson B, Katz P, Rajan S (1994) Magnesium deficiency in the eosinophilia-myalgia syndrome. Report of clinical and biochemical improvement with repletion. Arth Rheum 37: 1331\u20131334","journal-title":"Arth Rheum"},{"key":"50690444204_CR7","first-page":"132","volume":"34","author":"J Duffy","year":"1991","unstructured":"Duffy J, Engel AG, Bowles C (1991) Eosinophilia-myalgia syndrome: not associated with l-tryptophan. Arth Rheum 34: S132 (abstract)","journal-title":"Arth Rheum"},{"key":"50690444204_CR8","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1248\/cpb.40.2236","volume":"40","author":"Y Goda","year":"1992","unstructured":"Goda Y, Suzuki J, Maitani T, Yoshihira K, Takeda M, Uchiyama M (1992) 3-anilino-l-alanine, structural determination of UV-5, a contaminant in EMS-associated l-tryptophan samples. Chem Pharm Bull 40: 2236\u20132238","journal-title":"Chem Pharm Bull"},{"key":"50690444204_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0046-8177(91)90055-T","volume":"22","author":"MK Herrick","year":"1991","unstructured":"Herrick MK, Chang Y, Horoupian DS, Lombard CH, Adornato BT (1991) l-Tryptophan and the eosinophilia-myalgia syndrome: Pathologic findings in eight patients. Hum Pathol 22: 12\u201321","journal-title":"Hum Pathol"},{"key":"50690444204_CR10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM199003293221301","volume":"322","author":"PA Hertzman","year":"1990","unstructured":"Hertzman PA, Blevins WL, Mayer J, Greenfield B, Ting M, Gleich GJ (1990) Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med 322: 869\u2013873","journal-title":"N Engl J Med"},{"key":"50690444204_CR11","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1002\/art.1780360106","volume":"36","author":"P Hertzman","year":"1993","unstructured":"Hertzman P, Clauw D, Kaufman L, Silver R, Varga J, Callahan L, Pincus T (1993) 18\u201324 Month structured follow-up of 210 patients with eosinophilia-myalgia syndrome (EMS) in 12 States. Arth Rheum 36: R26 (abstract)","journal-title":"Arth Rheum"},{"key":"50690444204_CR12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/art.1780350308","volume":"35","author":"JR Hibbs","year":"1992","unstructured":"Hibbs JR, Mittleman B, Hill P, Medsger TA (1992) l-Tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak. Arth Rheum 35: 299\u2013303","journal-title":"Arth Rheum"},{"key":"50690444204_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0278-6915(92)90139-C","volume":"30","author":"J Ito","year":"1992","unstructured":"Ito J, Hosaki Y, Torigoe Y, Sakimoto K (1992) Identification of substances formed by decomposition of peak E substance in tryptophan. Food Chem Toxicol 30: 71\u201381","journal-title":"Food Chem Toxicol"},{"key":"50690444204_CR14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1172\/JCI116300","volume":"91","author":"LA Love","year":"1993","unstructured":"Love LA, Rader JI, Crofford LJ, Raybourne RB, Principato MA, Page SW, Trucksess MW, Smith MJ, Dugan EM, Tumer ML, Zelazowski E, Zelazowski P, Sternberg EM (1993) Pathological and immunological effects of ingesting l-tryptophan and 1,1\u2032-ethylidenebis (l-tryptophan) in Lewis rats. J Clin Invest 91: 804\u2013811","journal-title":"J Clin Invest"},{"key":"50690444204_CR15","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.2270484","volume":"250","author":"AN Mayeno","year":"1990","unstructured":"Mayeno AN, Lin F, Foote CS, Loegering DA, Ames MM, Hedberg CW, Gleich GJ (1990) Characterization of \u201cPeak E\u201d, a novel amino acid associated with eosinophilia-myalgia syndrome. Science 250: 1707\u20131708","journal-title":"Science"},{"key":"50690444204_CR16","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0025-6196(12)61142-2","volume":"67","author":"AN Mayeno","year":"1992","unstructured":"Mayeno AN, Belongia EA, Lin F, Lundy SK, Gleich GJ (1992) 3(Phenylamino) alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayo Clin Proc 67: 1134\u20131139","journal-title":"Mayo Clin Proc"},{"key":"50690444204_CR17","first-page":"285","volume":"89","author":"MA Patmas","year":"1992","unstructured":"Patmas MA (1992) Eosinophilia myalgia syndrome not associated with l-tryptophan. J Med Soc NJ 89: 285","journal-title":"J Med Soc NJ"},{"key":"50690444204_CR18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archinte.1991.00400030083015","volume":"151","author":"RM Philen","year":"1991","unstructured":"Philen RM, Eidson MA, Kilbourne EM, Sewell CM, Voorhees R (1991) Eosinophilia-myalgia syndrome \u2014 a clinical case series of 21 patients. Arch Int Med 151: 533\u2013537","journal-title":"Arch Int Med"},{"key":"50690444204_CR19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/oxfordjournals.aje.a116841","volume":"138","author":"RM Philen","year":"1993","unstructured":"Philen RM, Hill RH, Flanders WD, Caudill SP, Needham L, Sewell L, Sampson EJ, Falk H, Kilbourne EM (1993) The eosinophilia-myalgia studies of Oregon, New York, and New Mexico. Am J Epidemiol 138: 154\u2013159","journal-title":"Am J Epidemiol"},{"key":"50690444204_CR20","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI117125","volume":"93","author":"RM Silver","year":"1994","unstructured":"Silver RM, Ludwicka A, Hampton M, Ohba T, Bingel SA, Smith T, Harley RA, Maize J, Heyes MP (1994) A murine model of the eosinophilia myalgia syndrome induced by 1,1\u2032-ethylidenebis (tryptophan). J Clin Invest 93: 1473\u20131480","journal-title":"J Clin Invest"},{"key":"50690444204_CR21","first-page":"292A","volume":"42","author":"WO Spitzer","year":"1994","unstructured":"Spitzer WO, Haggerty J, Tamblyn E, Berkson L, Elmore J, Horwitz RI (1994) Continuing occurrence of eosinophilia myalgia syndrome. Clin Res 42: 292A (abstract)","journal-title":"Clin Res"},{"key":"50690444204_CR22","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/jama.1990.03450130070029","volume":"264","author":"LA Swygert","year":"1990","unstructured":"Swygert LA, Maes EF, Sewell LE, Miller L, Falk H, Kilbourne EM (1990) Eosinophilia-myalgia syndrome: results of nationwide surveillance. JAMA 264: 1698\u20131703","journal-title":"JAMA"},{"key":"50690444204_CR23","first-page":"56","volume":"6","author":"HD Tazelaar","year":"1993","unstructured":"Tazelaar HD, Myers JL, Strickler JG, Colby TV, Duffy J (1993) Tryptophan-induced lung disease: an immunophenotypic, immunofluorescent, and electron microscopic study. Mod Pathol 6: 56\u201360","journal-title":"Mod Pathol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s002040050197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s002040050197\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s002040050197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:31:53Z","timestamp":1558625513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s002040050197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["50690444204"],"URL":"https:\/\/doi.org\/10.1007\/s002040050197","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}